RxDoctor Payments Data

Courtland Watson, OD

Optometrist · Roseville, MNNPI 1093749434

Payments from drug & device makers

What this record shows

Coopervision Inc. accounts for 75.4% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2023 at $2,512 and has fallen 87.5% since, to $315 in 2025. Among optometrist clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,169in general payments, 2019–2025

Across 55 payments — averaging $93.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Coopervision Inc.$4K
  • Alcon$939
  • Johnson & Johnson Vision Care, Inc.$138
  • ABB Con-cise Optical Group LLC$134
  • Optos, Inc.$48
  • Oyster Point Pharma, Inc.$15

What the payments were for

  • Travel & lodging$2,26944%
  • Food & beverage$2,90056%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,169 in reported general payments places this provider in the 95th percentile of 826 optometrist providers in Minnesota.

See all optometrist providers in Minnesota

Medicare billing

Part B allowed, 2024
$36,113
Medicare patients
250
Services billed
1,845

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Latanoprost45$704

Paid to pharmacies, not to this prescriber.

Other optometrist in Roseville

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →